反応式
[Br:1][C:2]1[N:3]=[C:4](Br)[C:5]2[N:6]([CH:8]=[CH:9][N:10]=2)[CH:7]=1.C(N(CC)CC)C.Cl.Cl.[NH2:21][C:22]1[N:23]=[C:24]([NH:29][CH2:30][CH2:31][NH2:32])[S:25][C:26]=1[C:27]#[N:28]>CS(C)=O>[NH2:21][C:22]1[N:23]=[C:24]([NH:29][CH2:30][CH2:31][NH:32][C:4]2[C:5]3[N:6]([CH:8]=[CH:9][N:10]=3)[CH:7]=[C:2]([Br:1])[N:3]=2)[S:25][C:26]=1[C:27]#[N:28]参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
反応条件
- 温度
- 140 °C
実験手順
300 mg (1.08 mmol) of 6,8-dibromoimidazo[1,2-a]pyrazine were dissolved in 10 ml of DMSO, and 0.6 ml (4.3 mmol) of triethylamine and 360 mg (1.3 mmol) of 4-amino-2-[(2-aminoethyl)amino]-1,3-thiazole-5-carbonitrile dihydrochloride (Example 8A) were added. The mixture was heated at 140° C. in a microwave for 1 h. Purification by preparative HPLC gave 376 mg (83% of theory) of the product as a solid.
後処理
- customPurification by preparative HPLC
出典と根拠
- ORDレコード
- ord-5bfda0b3f3b64eefb76a883114688c89
- 出典データセット
- uspto-grants-2016_09
- 特許番号
- US09434731B2
関連ノート
読み込み中…